Larvol Delta - Dosefinding-Study-of-YMI024-to-Assess-Efficacy-Safety-and-Tolerability-in-Adults-With-Stable-Coronary-Artery-Disease-and-Elevated-hsCRP

YMI024 - Novartis

http://clinicaltrials.gov/ct2/show/NCT07830719

Sep 21, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next